Keyphrases
Orchiectomy
100%
Metabolic Consequences
100%
Gonadotropin-releasing Hormone
100%
Randomized Clinical Trial
100%
Insulin Resistance
100%
Confidence Interval
80%
Subcutaneous Adipose Tissue
60%
Lean Body Mass
60%
Fat Mass
60%
Visceral Adipose Tissue
60%
Androgen Deprivation Therapy
60%
Serum Cholesterol
40%
Gynoid Fat
40%
Advanced Prostate Cancer
40%
Triptorelin
40%
Fasting Plasma Glucose
40%
Android
40%
Fat Ratio
40%
Body Composition
40%
Data Combination
20%
Depot Injection
20%
Total Body Fat
20%
Serum Lipids
20%
Treatment Difference
20%
Fat Accumulation
20%
Dual X-ray Absorptiometry
20%
Hormone-naïve
20%
Pooled Analysis
20%
Linear Mixed Model
20%
Metabolic Changes
20%
Between-group Difference
20%
Subcapsular
20%
Low-density Lipoprotein
20%
Oral Glucose Tolerance Test
20%
High-density Lipoprotein Cholesterol (HDL-C)
20%
Nursing and Health Professions
Insulin Resistance
100%
Gonadorelin Agonist
100%
Orchiectomy
100%
Confidence Interval
80%
Fat Mass
80%
Lean Body Weight
60%
Androgen Deprivation Therapy
60%
Prostate Cancer
40%
Glucose Blood Level
40%
Cholesterol Blood Level
40%
Body Composition
40%
Oral Glucose Tolerance Test
20%
Dual Energy X Ray Absorptiometry
20%
High Density Lipoprotein
20%
Lipid Blood Level
20%
Low Density Lipoprotein
20%
Medicine and Dentistry
Gonadorelin Agonist
100%
Clinical Study
100%
Orchiectomy
100%
Adipose Tissue
100%
Insulin Resistance
83%
Lean Body Weight
50%
Androgen Deprivation Therapy
50%
Triptorelin
33%
Prostate Cancer
33%
Lipid Storage
16%
High-Density Lipoprotein
16%
Pooled Analysis
16%
Low-Density Lipoprotein
16%
Dual-Energy X-Ray Absorptiometry
16%
Mixed Model
16%
Oral Glucose Tolerance Test
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
100%
Gonadorelin Agonist
100%
Insulin Resistance
100%
Androgen
60%
Prostate Cancer
40%
Triptorelin
40%
Low Density Lipoprotein
20%
Mixed Model
20%
High Density Lipoprotein
20%